ImmunityBio Inc. Common Stock vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.6 (market cap $94.14M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 109.7× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days on average.
| IBRX | MSTZ | |
|---|---|---|
Market Cap | $10.33B | $94.14M |
Volume | 11,745,198 | 64,690,426 |
Sector | Health | Leveraged / Inverse |
52-Week High | $11.55 | $27.92 |
52-Week Low | $1.98 | $2.29 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $10.79B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MSTZ is currently trading at $2.66, showing strong daily momentum with a 13.43% gain. The technical picture remains bearish overall despite the recent price surge, with moving averages signaling continued downward pressure. Key financial ratios including P/E, P/S, and P/B are unavailable, limiting fundamental visibility. The stock faces significant resistance at the $3 level across multiple technical indicators.
The outlook remains cautious given the bearish technical signals and lack of transparent financial metrics. While the recent price surge indicates short-term momentum, investors face substantial uncertainty due to limited fundamental data availability. The primary risk involves the stock's inability to break through the $3 resistance zone, which could trigger renewed selling pressure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →